These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26455511)

  • 21. Clinical and investigational use of proteasome inhibitors for transplant rejection.
    Sadaka B; Alloway RR; Woodle ES
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1535-42. PubMed ID: 21916809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-Mediated Rejection Treatment With Bortezomib in Renal Transplant Recipients: A Single-Center 24-Month Follow-up Case Report.
    Bahena Méndez J; López Y López LR; Sebastián Díaz MA; Trejo Curiel I; Galindo-Lopéz R; Baca Córdova A; Wasung de Lay M; Vázquez Dávila RA; Zarate Rodríguez PA; Carmona-Escamilla MA
    Transplant Proc; 2020 May; 52(4):1123-1126. PubMed ID: 32224016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of bortezomib to cure acute antibody-mediated rejection in a non-compliant renal transplant patient.
    Ryckewaert A; Allain-Launay E; Moreau A; Blancho G; Cesbron A; Blin N; Roussey G
    Pediatr Transplant; 2013 Sep; 17(6):E131-6. PubMed ID: 23834525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome inhibitor therapy for antibody-mediated rejection.
    Woodle ES; Walsh RC; Alloway RR; Girnita A; Brailey P
    Pediatr Transplant; 2011 Sep; 15(6):548-56. PubMed ID: 21884344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib for acute humoral rejection in two repeat transplant recipients.
    Hardinger KL; Alford K; Murillo D
    Clin Transpl; 2009; ():479-83. PubMed ID: 20524319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of antibody-mediated rejection in kidney transplant recipients: a single-center experience with a bortezomib-based regimen.
    Nigos JG; Arora S; Nath P; Hussain SM; Marcus RJ; Ko TY; Sureshkumar KK
    Exp Clin Transplant; 2012 Dec; 10(6):609-13. PubMed ID: 23216567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.
    Waiser J; Budde K; Schütz M; Liefeldt L; Rudolph B; Schönemann C; Neumayer HH; Lachmann N
    Nephrol Dial Transplant; 2012 Mar; 27(3):1246-51. PubMed ID: 21852274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: a single-center experience.
    Cicora F; Paz M; Mos F; Roberti J
    Transpl Immunol; 2013 Dec; 29(1-4):7-10. PubMed ID: 23994721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bortezomib for antibody-mediated rejection of kidney transplant in youth: Associations with donor-specific antibody.
    Fulchiero R; Galea L; Hewlett J; Savant JD; Lopez S; Amaral S; Viteri B
    Pediatr Transplant; 2024 Aug; 28(5):e14774. PubMed ID: 38808699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibitor treatment of antibody-mediated allograft rejection.
    Woodle ES; Alloway RR; Girnita A
    Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteasome inhibitor-based therapy for antibody-mediated rejection.
    Walsh RC; Alloway RR; Girnita AL; Woodle ES
    Kidney Int; 2012 Jun; 81(11):1067-74. PubMed ID: 22336990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: report of three cases and review of literature.
    Tzvetanov I; Spaggiari M; Joseph J; Jeon H; Thielke J; Oberholzer J; Benedetti E
    Transplant Proc; 2012 Dec; 44(10):2971-5. PubMed ID: 23195008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-mediated rejection in kidney transplantation: an update.
    Lucas JG; Co JP; Nwaogwugwu UT; Dosani I; Sureshkumar KK
    Expert Opin Pharmacother; 2011 Mar; 12(4):579-92. PubMed ID: 21294653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Incidence of Paralytic Ileus After Bortezomib Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients: Report of 2 Cases.
    De Sousa-Amorim E; Revuelta I; Diekmann F; Cofan F; Cid J; Lozano M; Campistol JM; Oppenheimer F
    Transplantation; 2015 Nov; 99(11):e170-1. PubMed ID: 26492053
    [No Abstract]   [Full Text] [Related]  

  • 37. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective therapy for acute antibody-mediated rejection with mild chronic changes: case report and review of the literature.
    Gheith O; Al-Otaibi T; Nampoory N; Halim M; Nair P; Saied T; Al-Waheeb S; Muzeirei I; Ibraheim M
    Exp Clin Transplant; 2012 Aug; 10(4):406-9. PubMed ID: 22746156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteasome inhibition reduces donor-specific antibody levels.
    Everly MJ; Everly JJ; Susskind B; Brailey P; Arend LJ; Alloway RR; Roy-Chaudhury P; Govil A; Mogilishetty G; Rike AH; Cardi M; Wadih G; Brown E; Tevar A; Woodle ES
    Transplant Proc; 2009; 41(1):105-7. PubMed ID: 19249489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
    Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
    Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.